Autologous CD34+ Intimate Repair: Lecheng Briefing on Yueyin Regenerative Care

Public reports from Boao Lecheng briefing describes “Yueyin Gentle Care · Yunmei Regeneration”: autologous blood–derived progenitor cells (including CD34+) for vaginal health and repair. Figures below are source claims, not a personal prognosis. Confirm indication, operator credentials, and price in writing.

Mechanism as stated

Same-body compatibility: CD34+ progenitors may differentiate toward mucosal epithelium, fibroblasts, and vascular endothelium. The post says VEGF from these cells is 8–10× ordinary plasma. Concentrates also contain PDGF, TGF-β, and fibronectin. It claims a single session can raise type-III collagen secretion by 65% for six months or more.

Microbiome: vaginal pH 4.0–4.5 to favor lactobacilli, with more IL-10. An animal study in the post reports Gardnerella detection down 72% vs control and lactobacilli at 89%.

Five clinical claims in the post

Postpartum: fibrin seal by 24 h, epithelial cover by 72 h, scar width −40% at 2 weeks; vs suture, VAS −3 and sexual recovery 50% faster. Recurrent vaginitis/cervicitis: fibrin barrier plus Th1/Th2 shift; a 200-patient multicenter series with 6-month relapse 38%→9%. Laxity: muscle thickness +22%, elastic modulus +35%, pelvic EMG +41%, incontinence −60%, FSFI +5.2. Pigment: perfusion and tyrosinase inhibition; MI −2.1 after three sessions. Dysbiosis: lactobacillus dominance, amines down, Shannon index ×1.8.

Intended groups in the post: postpartum repair, recurrent inflammation, microbiome imbalance, and intimate anti-aging.

Limits

The article cites adverse-event rate <0.3% and notes results vary with age, hormones, and comorbidities; regeneration declines with age; severe laxity needs pelvic-floor training; infection still needs antimicrobials.

Cited sources include a 2024 Chinese expert consensus on gynecologic autologous PRP and several journal entries. Marketing numbers do not replace an individual work-up. Verify license, indication, and a written estimate before travel.

The Boao Lecheng International Medical Tourism Pilot Zone, approved by the State Council in February 2013, pilots franchised medical care, health management, and aesthetic medicine—aiming for “three synchronizations” of technology, equipment, and drugs with international standards.